Capital Research Global Investors
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1422848
Los Angeles, CA
Position in REGN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$78,725,062
-$1,036,896 QoQ
Shares Held
101,891
-1.4% QoQ
Ownership
0.099%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Capital Research Global Investors holds $14,161,458,348 across 17 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
19,490,637 | $9,681,584,117 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
9,750,699 | $2,935,252,919 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
3,504,387 | $200,521,024 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
5,344,701 | $199,197,006 | |
| 5 | TECH |
BIO-TECHNE Corp
|
2,621,890 | $185,236,528 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,532,303 | $170,131,602 | |
| 7 | KYMR |
Kymera Therapeutics, Inc.
|
1,388,881 | $159,262,984 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,686,625 | $143,683,583 |
All Filings in REGN
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $78,725,062 | 101,891 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $79,761,958 | 103,336 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $59,459,490 | 105,749 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $53,609,850 | 102,114 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $52,078,527 | 82,113 | Shares | Defined | 2025-05-12 | |
| 2024-09-30 | $677,911,036 | 644,868 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $587,301,900 | 558,787 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $379,396,233 | 394,182 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $356,940,569 | 406,404 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $340,202,611 | 413,389 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $302,536,955 | 421,044 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $345,955,936 | 421,040 | Shares | Defined | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||